CD63 and neoplasm: Tumor or TME-derived sEVs can modulate tumor progression by transporting specific metabolites to distant tissues, immune cells, etc. For instance, colon cancer cells expressing CD63, CD9 and A33 are known to deliver exosomal phosphatidylcholine to liver tissues via the portal vein (Kumar et al., 2021).